NLRP3 Inflammasome Inhibitor BAY-117082 Reduces Oral Squamous Cell Carcinoma Progression

NLRP3 Inflammasome Inhibitor BAY-117082 Reduces Oral Squamous Cell Carcinoma Progression

Oral cancer is one of the most common human malignancies, and its incidence is increasing worldwide. In particular, oral squamous cell carcinoma (OSCC) is characterized by high rates of proliferation, invasiveness, and metastasis. Currently, standard treatment for OSCC includes surgical removal, che...

Full description

Bibliographic Details
Main Authors: Sarah Adriana Scuderi, Giovanna Casili, Rossella Basilotta, Marika Lanza, Alessia Filippone, Gabriele Raciti, Ivana Puliafito, Lorenzo Colarossi, Emanuela Esposito, Irene Paterniti
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:International Journal of Molecular Sciences
Subjects:
oral cancer
oral squamous cell carcinoma (OSCC)
NOD-like receptor family pyrin domain containing 3 inflammasome (NLRP3)
apoptosis
Online Access:https://www.mdpi.com/1422-0067/22/20/11108

Internet

https://www.mdpi.com/1422-0067/22/20/11108

Similar Items